BIRC5 and acute myeloid leukemia: These finding are consistent with previously published survival analysis using TCGA database demonstrating prolonged survival in AML patients with lower survivin expression.37 Furthermore, our analysis of this database of 168 adult AML patients confirmed that patients with low MUC1 expression showed significantly prolonged overall survival (P = .02, data not shown).